UBS AM
JANX icon

UBS AM’s Janux Therapeutics JANX Stock Holding History

UBS AM’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.22M Buy
87,757
+12,259
+16% +$168K ﹤0.01% 2260
2025
Q4 		$1.04M Buy
75,498
+9,173
+14% +$216K ﹤0.01% 2121
2025
Q3 		$1.62M Sell
66,325
-45,037
-40% -$1.1M ﹤0.01% 1834
2025
Q2 		$2.57M Sell
111,362
-75,032
-40% -$1.98M ﹤0.01% 2036
2025
Q1 		$5.03M Buy
186,394
+20,657
+12% +$779K ﹤0.01% 1571
2024
Q4 		$8.87M Buy
165,737
+139,543
+533% +$7.38M ﹤0.01% 1307
2024
Q3 		$1.19M Sell
26,194
-3,984
-13% -$173K ﹤0.01% 2309
2024
Q2 		$1.26M Buy
30,178
+21,483
+247% +$1.01M ﹤0.01% 2254
2024
Q1 		$327K Buy
+8,695
New +$189K ﹤0.01% 2384

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return